Rush University Medical Center
Radiation Oncology residency · Chicago, IL · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is Rush University Medical Center's research in radiation oncology, which the program shares with other departments and affiliated hospitals.
About Rush University Medical Centerinstitution-wide radiation oncology research
Radiation Oncology publications from Rush University Medical Center and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
81
works per year
37th of 47 radiation oncology residency programs
-7.7%
2-year growth
43rd of 47 radiation oncology residency programs
16.9%
in top 10% of field (works before 2025)
39th of 47 radiation oncology residency programs
33.9%
cited above world average
42nd of 47 radiation oncology residency programs
Works per year · * 2026 so far
Oncology · 248Radiology, Nuclear Medicine and Imaging · 145
Radiation Oncology research topics at Rush University Medical Center
Papers in the window; each links to the list on OpenAlex.
- Cancer Immunotherapy and Biomarkers 39
- Cardiac Imaging and Diagnostics 38
- Cutaneous Melanoma Detection and Management 34
- Advanced Neuroimaging Techniques and Applications 31
- Cancer survivorship and care 14
- Pancreatic and Hepatic Oncology Research 14
- COVID-19 and healthcare impacts 14
- Advanced MRI Techniques and Applications 13
Most cited at Rush University Medical Center since 2024
All radiation oncology papers there on OpenAlex
- Spatial transcriptomic analysis of primary and metastatic pancreatic cancers highlights tumor microenvironmental heterogeneityAteeq Muhammed Khaliq et al. · Nature Genetics · 2024 · PubMed · cited 132
- Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension studyMartin Reck et al. · Lung Cancer · 2024 · PubMed · cited 88
- Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, immune activation and extracellular matrix reorganization in the tumor microenvironmentBrenda C O’Connell et al. · Journal for ImmunoTherapy of Cancer · 2024 · PubMed · cited 84
- Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(−) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practiceManali Ajay Bhave et al. · Breast Cancer Research and Treatment · 2024 · PubMed · cited 61
- Global estimates of prevalence of chronic painful neuropathy and moderate-to-severe neuropathy among patients with chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis of data from 29 countries between 2000 and 2024Ryan Steven D'Souza et al. · Regional Anesthesia & Pain Medicine · 2025 · PubMed · cited 59
- Concurrent Chemoradiation ± Atezolizumab (atezo) in Limited-Stage Small Cell Lung Cancer (LS-SCLC): Results of NRG Oncology/Alliance LU005Kyndra S. Higgins et al. · International Journal of Radiation Oncology*Biology*Physics · 2024 · cited 57
- Outcomes and Techniques of Robotic-Assisted Partial Nephrectomy (RAPN) for Renal Hilar Masses: A Comprehensive Systematic ReviewSavio Domenico Pandolfo et al. · Cancers · 2024 · PubMed · cited 51
- Immune Checkpoint Inhibitors and Cardiotoxicity: A Comparative Meta‐Analysis of Observational Studies and Randomized Controlled TrialsAkash Sharma et al. · Journal of the American Heart Association · 2024 · PubMed · cited 49
- MRI free water mediates the association between diffusion tensor image analysis along the perivascular space and executive function in four independent middle to aged cohortsXiaodan Liu et al. · Alzheimer s & Dementia · 2024 · PubMed · cited 37
- Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi techniqueEmily J. Gallagher et al. · npj Breast Cancer · 2024 · PubMed · cited 37